Driving Under the Influence of Medication: New Laws and What Drivers Need to Recognize
As of April 2nd, significant changes to road traffic laws are coming into effect, dramatically increasing penalties for driving under the influence of medication. These changes, mirroring the severity of penalties for drunk driving, aim to address a previously under-regulated area of road safety. The new legislation also introduces a ‘drug measurement refusal’ clause, carrying substantial penalties.
The Rise of ‘Drug Driving’ and the Legal Response
For years, driving while impaired by medication has been a grey area in traffic law. While the dangers are clear – reduced concentration, drowsiness and impaired reaction times – enforcement and penalties often lagged behind those for alcohol-related offenses. This is changing. The updated laws recognize that impairment isn’t limited to alcohol or illicit drugs; everyday medications, including over-the-counter remedies, can significantly compromise a driver’s ability to operate a vehicle safely.
What Medications Are Affected?
The scope of this legislation is broad. It’s not just about illegal narcotics. Common medications like cold remedies and allergy medications are now under scrutiny. Specifically, antihistamines are a key concern. The Korean Pharmacists Association has already released a list of medications to be cautious with, categorizing them by risk level.
Antihistamine Risk Levels: A Closer Look
The impact of antihistamines on driving ability varies depending on the generation of the drug. Newer generations (2nd and 3rd) generally cause less drowsiness and reduced concentration compared to older formulations. However, even newer antihistamines are categorized into levels of risk:
- Level 0-1 (Caution): Fexofenadine (e.g., Allegra 120mg) is considered relatively safe, with minimal central nervous system effects due to its low blood-brain barrier permeability.
- Level 1 (Driving Caution): Desloratadine, Loratadine, Rupatadine, Evastin, Epinastine, and Emedastine may cause some attention deficits in certain individuals.
- Level 2 (Driving Risk): Levocetirizine, Cetirizine, Mizolastine, Bepotastine, Olopatadine, Azelastine, and Ketotifen carry a higher risk of drowsiness and impaired concentration.
It’s crucial to remember that individual reactions to medication can vary. Even with newer antihistamines, first-time users should be particularly cautious and assess their response before driving.
The New ‘Refusal to Test’ Law
A key component of the updated legislation is the introduction of a ‘drug measurement refusal’ clause. If a police officer suspects a driver is impaired by medication and requests a test, refusing that test is now a criminal offense. Refusal can result in a prison sentence of up to five years or a fine of up to 20 million Korean Won.
Pharmacists’ Role in Promoting Road Safety
With these changes, the role of pharmacists is becoming increasingly important. Pharmacists are now expected to counsel patients on the potential side effects of medications, particularly those that can impair driving ability. This includes asking about driving habits and recommending safer alternatives when appropriate.
Experts emphasize that this is a societal shift. There’s a growing recognition that medication, while essential for treatment, can have consequences for road safety. Choosing medications with lower risk profiles, like fexofenadine when possible, can be a proactive step for frequent drivers.
FAQ
Q: What happens if I refuse a drug test?
A: You could face up to 5 years in prison or a fine of up to 20 million Korean Won.
Q: Are all antihistamines dangerous to grab before driving?
A: No, the risk varies. Newer generations generally have fewer side effects, and fexofenadine is considered relatively safe.
Q: What should I do if I’m unsure about a medication’s effect on my driving?
A: Consult with your doctor or pharmacist.
Q: Does this law only apply to prescription medications?
A: No, it applies to all medications, including over-the-counter drugs.
Q: What is the blood-brain barrier and why is it important?
A: The blood-brain barrier is a protective mechanism that limits the passage of substances from the bloodstream into the brain. Fexofenadine has a low permeability, meaning it doesn’t readily affect the central nervous system.
Pro Tip: Always check the label of any medication for warnings about driving or operating machinery. When in doubt, inquire your pharmacist.
Did you know? The Korean Pharmacists Association has published a list of medications categorized by their potential impact on driving ability.
Stay informed and prioritize safety. The updated road traffic laws are designed to protect all road users. By understanding the risks and taking appropriate precautions, drivers can ensure they remain safe and compliant with the law.
Explore More: Read the full details of the updated road traffic law here.
